Dopamine agonist withdrawal in hyperprolactinemia: when and how

Roberto Salvatori

doi:10.1007/s12020-017-1469-0

Dopamine agonist withdrawal in hyperprolactinemia: when and how

School of Medicine

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Pages (from-to)	4-6
Number of pages	3
Journal	Endocrine
Volume	59
Issue number	1
DOIs	https://doi.org/10.1007/s12020-017-1469-0
State	Published - Jan 1 2018

ASJC Scopus subject areas

Endocrinology, Diabetes and Metabolism
Endocrinology

Access to Document

10.1007/s12020-017-1469-0

Cite this

@article{eeb124101fd3409393351caf78b5899c,

title = "Dopamine agonist withdrawal in hyperprolactinemia: when and how",

author = "Roberto Salvatori",

year = "2018",

month = jan,

day = "1",

doi = "10.1007/s12020-017-1469-0",

language = "English (US)",

volume = "59",

pages = "4--6",

journal = "Endocrine",

issn = "1355-008X",

publisher = "Humana Press",

number = "1",

}

TY - JOUR

T1 - Dopamine agonist withdrawal in hyperprolactinemia

T2 - when and how

AU - Salvatori, Roberto

PY - 2018/1/1

Y1 - 2018/1/1

UR - http://www.scopus.com/inward/record.url?scp=85033503326&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85033503326&partnerID=8YFLogxK

U2 - 10.1007/s12020-017-1469-0

DO - 10.1007/s12020-017-1469-0

M3 - Editorial

C2 - 29124662

AN - SCOPUS:85033503326

SN - 1355-008X

VL - 59

SP - 4

EP - 6

JO - Endocrine

JF - Endocrine

IS - 1

ER -

Dopamine agonist withdrawal in hyperprolactinemia: when and how

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this